FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a ...
Tag: Ligand
Novel bladder cancer treatment gains MHRA approval in the UK
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
Optibrium, a leading developer of software and AI solutions for molecular design today announced the publication of a peer-reviewed study ...
ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class ...
AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods
In a recent study published in the journal Science Advances, researchers in Sweden conducted virtual screens of over 16 million ...
Review of fasting-mimicking diets in cancer treatment
In a recent review published in Cell Metabolism, researchers present the role of cyclic fasting and fasting-mimicking diets (FMD) in ...
Study unveils dual roles of TNF-α receptors in tissue regeneration and cell death
A study published in The EMBO Journal opens new perspectives to better understand how the molecular mechanisms involved in regenerative ...
Study shows how cancer can selfishly hijack a helpful immune pathway to spread
A study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine discovered a new relationship ...
Revolutionizing drug discovery: Giga-scale screening unleashes power of AI and virtual libraries
In a recent review published in the journal Nature, researchers examined recent breakthroughs in ligand discovery tools, their potential to ...
Self-directed autoantibodies against certain chemokines may protect against long-COVID
A recent study published in the journal Nature Immunology discovered autoantibodies against chemokines following severe acute respiratory syndrome coronavirus 2 ...
